FDA highlights next steps for Bisphenol A assessment

摘要

In the continuing search for answers on the safety of Bisphenol A (BPA), the United States Food and Drug Administration (FDA) plans to open a public docket on the chemical, seeking comment on the agency's review of low dose toxicity studies and recently published research, independent evaluations commissioned by FDA's chief scientist, and other materials.rn"The agency welcomes comments on these documents, other available evidence, and the agency's regulatory options," FDA says on its website. "This docket will be open for public comment for 60 days."